MedPath

Randomize comparison of vaginal suppository containing cuminum cyminum essential oil with vaginal clotrimazole versus placebo vaginal suppository for vulvovaginal candidiasis treatment

Phase 1
Recruiting
Conditions
Candidiasis vulvovaginitis.
Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere
N77.1
Registration Number
IRCT20150706023084N11
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

Women aged 18 - 50 years old
Being married
Signature of consent
Diagnosis of candidiasis infection
lack of sensitivity to cuminum cyminum or clotrimazole

Exclusion Criteria

Pregnancy
lactation
menopause
Underlying diseases
Menstruation during the study
Forget one dose or more of medication
Allergy to clotrimazole or cuminum cyminum suppository
The patient's unwillingness to continue treatment
Abnormal uterine bleeding

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Itching. Timepoint: Beginning of the study - 7 days after the start of the study. Method of measurement: Questionnaire - completing a checklist to evaluate the symptoms of candidal vaginitis and then compare the frequency of symptoms of candidial vaginitis within and between the two treatment groups.;Discharge. Timepoint: Beginning of the study - 7 days after the start of the study. Method of measurement: Questionnaire.;Inflammation. Timepoint: Beginning of the study - 7 days after the start of the study. Method of measurement: Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath